Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Clinical-trials-phase-ii crawled date : 2021 - 04 - 29 save search
Cara Therapeutics Announces Topline Results From KARE Phase 2 Dose-Ranging Trial of Oral KORSUVA™ in Atopic Dermatitis Patients with Moderate-to-Severe Pruritus
Published: 2021-04-29 (Crawled : 15:00) - biospace.com/
CARA | $0.69 -5.73% -6.07% 360K
|
Health Technology
|
| O: -43.48%
H: 11.0%
C: -3.47%
phase 2 results dermatitis topline trial atopic dermatitis
PDS Biotech Announces Oral Presentation of PDS0101 Data by the National Cancer Institute at 2021 American Society of Clinical Oncology Annual Meeting
Published: 2021-04-29 (Crawled : 14:00) - biospace.com/
PDSB | $2.9 6.62% 5.88% 1.1M
|
Health Technology
|
| O: 1.0%
H: 0.81%
C: -6.24%
presentation cancer biotech iot
HUTCHMED Initiates Phase II Registration Study of HMPL-689 in Patients with Follicular Lymphoma and Marginal Zone Lymphoma in China
Published: 2021-04-29 (Crawled : 08:00) - biospace.com/
HCM | $16.36 -0.55% -0.43% 0
|
Health Technology
|
| O: 0.82%
H: 1.08%
C: -3.34%
china
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
ZCMD | $1.45 5.84% 49.63% 15M
|
Commercial Services
AULT | $0.2421 -7.7% 45.23% 16M
|
Manufacturing
XPON | News | $3.15 63.21% 33.9% 100K
|
EGOX | $0.036 12.15% 31.56% 32M
|
TIRX | $0.8 65.02% 25.95% 410K
|
VTNR 4 | $1.31 33.78% 25.82% 220K
|
Industrial Services
GDHG | $0.263 21.76% 25.34% 1.3M
|
TPET | $0.3279 -3.56% 23.57% 11M
|
n/a
HOLO | $2.95 31.7% 22.49% 37M
|
MTNB | $0.19 -1.04% 14.58% 950K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.